Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
591 studies found for:    Open Studies | "Hormones"
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Not yet recruiting A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
Conditions: Growth Hormone Deficiency, Pediatric;   hGH (Human Growth Hormone);   Endocrine System Diseases;   Hormones;   Pituitary Diseases
Interventions: Drug: Once weekly subcutaneous injection of TransCon hGH;   Drug: Once daily subcutaneous injection of Genotropin
2 Recruiting Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Conditions: Hormone Receptor-Positive Breast;   Gynecologic;   Desmoid;   Hormone Receptor-Positive Neoplasms
Intervention: Drug: Z-Endoxifen
3 Not yet recruiting Dynamic Hormone Diagnostics in Endocrine Disease
Conditions: Adrenal Insufficiency;   Congenital Adrenal Hyperplasia;   Cushing Syndrome;   Growth Hormone Deficiency;   Acromegaly;   Primary Hyperaldosteronism
Intervention: Other: 27 hour subcutaneous fluid sampling
4 Recruiting Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children
Interventions: Drug: NNC0195-0092;   Drug: Norditropin® FlexPro® pen
5 Unknown  Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth hormone
6 Recruiting Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
Conditions: Obesity;   Short Stature;   Growth Hormone Deficiency
Interventions: Drug: Niacin;   Drug: Placebo
7 Unknown  Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth Hormone Replacement Therapy
8 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
9 Unknown  Efficacy of FWGE in Combination With Hormone Therapy for the Treatment of Hormone-Refractory Prostate Cancer Patients
Condition: Hormone Refractory Prostate Cancer
Intervention: Drug: Fermented Wheat germ extract
10 Recruiting Medico-economic Interest of Taking Into Account Circulating Tumor Cells (CTC) to Determine the Kind of First Line Treatment for Metastatic, Hormone-receptors Positive, Breast Cancers
Conditions: Ductal Infiltrating Metastatic Breast Cancer;   Hormone-receptors Positive Breast Cancer
Intervention: Biological: Circulating tumor cells counting at baseline
11 Recruiting Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency
Condition: Growth Hormone Deficiency With Pituitary Anomalies
Interventions: Drug: Macimorelin;   Drug: Insulin
12 Recruiting A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
Condition: Metastatic Hormone Sensitive Prostate Cancer
Interventions: Drug: Enzalutamide;   Drug: Placebo
13 Recruiting A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Condition: Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer
Interventions: Drug: LEE011;   Drug: Letrozole;   Drug: Tamoxifen;   Drug: Fulvestrant;   Drug: goserelin
14 Recruiting Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)
Conditions: Endometrial Carcinoma;   Metastatic Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: AZD2014;   Drug: Anastrozole
15 Unknown  Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer
Conditions: Hormone-Sensitive Breast Cancer;   Breast Cancer
Interventions: Drug: Letrozole;   Drug: Bevacizumab
16 Recruiting Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Conditions: Early-Stage Breast Carcinoma;   Hormone Receptor Positive Tumor
Interventions: Drug: Tamoxifen or Aromatase Inhibitor or Aromatase Inhibitor + goserelin;   Drug: Palbociclib
17 Recruiting Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: PEG-somatropin
18 Recruiting Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA and ISS in Children
Conditions: Growth Hormone Deficiency;   Turner Syndrome;   Chronic Renal Failure;   Small for Gestational Age;   Idiopathic Short Stature
19 Unknown  Study of Weekly ALTU-238 Compared With Daily Nutropin AQ in Prepubertal Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: Somatropin
20 Unknown  Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Condition: Hormone Receptor Positive Malignant Neoplasm of Breast
Interventions: Drug: Exemestane;   Drug: Everolimus

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years